Volume 132, Issue 4, Pages (April 2007)

Slides:



Advertisements
Similar presentations
Volume 130, Issue 2, Pages (February 2006)
Advertisements

Volume 132, Issue 1, Pages (January 2007)
Volume 132, Issue 3, Pages (March 2007)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 128, Issue 4, Pages (April 2005)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 130, Issue 1, Pages (January 2006)
Volume 140, Issue 2, Pages e2 (February 2011)
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 136, Issue 2, Pages (February 2009)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 134, Issue 4, Pages (April 2008)
Unexpected Role of Surface Transglutaminase Type II in Celiac Disease
Volume 138, Issue 7, Pages (June 2010)
Volume 143, Issue 4, Pages e9 (October 2012)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 132, Issue 1, Pages (January 2007)
Role of IL-9 in the pathophysiology of allergic diseases
Volume 134, Issue 4, Pages e2 (April 2008)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 132, Issue 7, Pages (June 2007)
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Interleukin 15 mediates epithelial changes in celiac disease
Volume 134, Issue 1, Pages (January 2008)
Volume 132, Issue 5, Pages (May 2007)
Volume 133, Issue 3, Pages (September 2007)
Volume 140, Issue 2, Pages (February 2011)
Natural History of Potential Celiac Disease in Children
Volume 141, Issue 3, Pages (September 2011)
Volume 150, Issue 4, Pages (April 2016)
Volume 21, Issue 3, Pages (September 2004)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 137, Issue 3, Pages (September 2009)
Volume 134, Issue 3, Pages (March 2008)
E. Cario, G. Gerken, D.K. Podolsky  Gastroenterology 
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 147, Issue 1, Pages (July 2014)
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 141, Issue 3, Pages (September 2011)
Volume 143, Issue 1, Pages (July 2012)
Volume 21, Issue 3, Pages (September 2004)
Volume 141, Issue 5, Pages e2 (November 2011)
T Cell-Derived Lymphotoxin Regulates Liver Regeneration
Role of Connective Tissue Growth Factor in Oval Cell Response During Liver Regeneration After 2-AAF/PHx in Rats  Liya Pi, Seh-Hoon Oh, Thomas Shupe, Bryon.
Volume 7, Issue 2, Pages (February 2010)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 145, Issue 1, Pages e3 (July 2013)
Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6- dependent mechanism1   Anil Mishra, Marc E Rothenberg  Gastroenterology 
Volume 137, Issue 1, Pages e5 (July 2009)
Volume 132, Issue 4, Pages (April 2007)
Volume 138, Issue 3, Pages e3 (March 2010)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 138, Issue 4, Pages (April 2010)
Volume 141, Issue 3, Pages (September 2011)
Volume 132, Issue 2, Pages (February 2007)
Volume 130, Issue 2, Pages (February 2006)
Volume 126, Issue 1, Pages (January 2004)
Michelle Maria Pietzak  Gastroenterology 
Volume 136, Issue 7, Pages (June 2009)
Volume 133, Issue 3, Pages (September 2007)
Volume 136, Issue 3, Pages (March 2009)
TSH Receptor and Thyroid-Specific Gene Expression in Human Skin
Interleukin-17 is Produced by Both Th1 and Th2 Lymphocytes, and Modulates Interferon-γ- and Interleukin-4-Induced Activation of Human Keratinocytes  Cristina.
Fibroblast Growth Factor 10 Induces Proliferation and Differentiation of Human Primary Cultured Keratinocytes  Cinzia Marchese, Alessandra Felici, Vincenzo.
Volume 146, Issue 4, Pages (April 2014)
Presentation transcript:

Volume 132, Issue 4, Pages 1245-1253 (April 2007) Humoral Immune Response to Tissue Transglutaminase Is Related to Epithelial Cell Proliferation in Celiac Disease  Maria V. Barone, Ivana Caputo, Maria T. Ribecco, Maria Maglio, Roberto Marzari, Daniele Sblattero, Riccardo Troncone, Salvatore Auricchio, Carla Esposito  Gastroenterology  Volume 132, Issue 4, Pages 1245-1253 (April 2007) DOI: 10.1053/j.gastro.2007.01.030 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Representative images of several similar experiments (>3). CUB 7402 dose-dependent induction of actin rearrangement in (A) Caco-2, (B) MCF7, and (C) NIH 3T3 cells. Arrows indicate membrane ruffles. (Original magnification 40×.) Gastroenterology 2007 132, 1245-1253DOI: (10.1053/j.gastro.2007.01.030) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Representative images of several similar experiments (>3). (A) Effect on actin rearrangement in Caco-2 cells of single-chain antibodies (clones 4.2 and 3.7) from patients with celiac disease and of a single-chain anti-tTG antibody from a healthy donor (clone D51). The effect of the anti-gliadin single-chain antibody (G2 clone) is also shown. (B) Effect of the recombinant anti-tTG mini-antibody clone 2.8 on actin rearrangement in Caco-2, MCF7, and NIH 3T3 cells. Arrows indicate membrane ruffles. (Original magnification 40×.) Gastroenterology 2007 132, 1245-1253DOI: (10.1053/j.gastro.2007.01.030) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 (A) CUB 7402 dose-dependently induced G0 → S transition in synchronized NIH 3T3 fibroblasts. Nonspecific rabbit IgG1 served as control. Values are normalized to BrdU incorporation of cells treated with 10% serum. Data are reported as means ± SDs from 3 separate experiments. *P < .05 vs untreated. (B) Induction of G0 → S transition in synchronized NIH 3T3 fibroblasts by commercial anti-tTG antibodies (CUB 7402, 2.5 μg/mL; TG100, 2.5 μg/mL; and rabbit polyclonal antibody, 1:500) and by single-chain anti-tTG antibodies (10 μg/mL). Values are normalized to BrdU incorporation of cells treated with 10% serum. Data are reported as means ± SDs from 3 separate experiments. *P < .05 vs untreated. (C) TUNEL assay of NIH 3T3 fibroblasts treated with 2.5 μg/mL IgG1, CUB 7402, or clone 2.8 (green). A positive control obtained by treatment with deoxyribonuclease I before the TUNEL assay is shown. Hoechst staining of nuclei is also shown (blue). Gastroenterology 2007 132, 1245-1253DOI: (10.1053/j.gastro.2007.01.030) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 (A) Surface tTG staining of unpermeabilized living cells (Caco-2, MCF7, and NIH 3T3). (Original magnification 40×.) (B) Effect of PD9859 plus CUB 7402 (2.5 μg/mL) on the G0 → S transition of synchronized NIH 3T3 fibroblasts. Values are normalized to BrdU incorporation of cells treated with 10% serum. Data are reported as means ± SDs from 2 separate experiments. *P < .05 vs untreated. Gastroenterology 2007 132, 1245-1253DOI: (10.1053/j.gastro.2007.01.030) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Surface tTG activity of whole NIH 3T3 cells in the presence of different amounts of CUB 7402 and 20 μg/mL of 2 single-chain anti-tTG antibodies. Data are reported as means ± SDs from 3 separate experiments performed in triplicate. Gastroenterology 2007 132, 1245-1253DOI: (10.1053/j.gastro.2007.01.030) Copyright © 2007 AGA Institute Terms and Conditions

Figure 6 (A) Confocal images of cytokeratin staining (green) and BrdU incorporation (red) in celiac disease epithelial mucosal cells of representative samples treated with medium alone or with 2.0 μg/mL antibodies (IgG1, CUB 7402, and clone 2.8 alone or in the presence of PD98059) (original magnification 20×). (B) Mean values ± SDs of BrdU incorporation in enterocytes of several patients with celiac disease. The number of biopsy specimens used for each experiment is indicated. *P < .05 vs cultures with medium. (C) Mean values ± SDs of BrdU incorporation in enterocytes of several nonceliac control patients. The number of biopsy specimens used for each experiment is indicated. (D) TUNEL assay of sections from celiac disease biopsy specimens cultured with medium alone or with 2.5 μg/mL antibodies (IgG1, CUB 7402, or clone 2.8) (green). A positive control obtained by treatment with deoxyribonuclease I before TUNEL assay is shown. Hoechst staining of nuclei is also shown (blue). Gastroenterology 2007 132, 1245-1253DOI: (10.1053/j.gastro.2007.01.030) Copyright © 2007 AGA Institute Terms and Conditions